Literature DB >> 12713500

Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience.

Vladimir Zotov1, Roman Shyyan.   

Abstract

The incidence of breast cancer and mortality from this disease remain high in countries with limited resources such as the Ukraine. Because of a lack of mammography equipment and formal screening programs, as well as educational and other factors, breast cancer is usually diagnosed in late stages in such countries. We report the experience of the PATH Breast Cancer Assistance Program in introducing a pilot breast cancer screening program in one territory of the Ukraine, the Chernihiv oblast. The program entailed educating the public, training health care providers in clinical breast examination (CBE) and mammography, opening a dedicated mammography facility, designating a center for breast cancer care, building diagnostic capacity, and fostering the formation of support groups. From 1998 to 2002, 18,000 women underwent screening with CBE and 8778 women underwent screening with mammography. When implementing the program we encountered various cultural, economic, and logistic difficulties, such as reservations about showing bare breasts in educational materials, the lack of an established system for collecting screening data, and barriers to follow-up in women with positive screening results. Screening mammography proved to be more effective in detecting small and nonpalpable lesions; 8.7% of cancers detected in the mammography group were in situ, compared with 0% in the CBE group. However, introduction of CBE as a screening modality required fewer financial resources compared with mammography and was recommended as a transitional method before the introduction of mammography screening programs in countries with limited resources. The introduction of screening was associated with favorable changes in indicators of breast cancer care, including an increase in the percentage of breast-preserving operations and new legislation to provide funding for breast cancer services. We conclude that this successful pilot program of breast cancer screening in a limited-resource setting can serve as an example for other similar programs.

Entities:  

Mesh:

Year:  2003        PMID: 12713500     DOI: 10.1046/j.1524-4741.9.s2.7.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

1.  Breast Cancer in Low and Middle Income Countries: How Can Guidelines Best Be Disseminated and Implemented?

Authors:  Benjamin O Anderson; Vivien D Tsu
Journal:  Breast Care (Basel)       Date:  2008-02-22       Impact factor: 2.860

2.  Computational Optics Enables Breast Cancer Profiling in Point-of-Care Settings.

Authors:  Jouha Min; Hyungsoon Im; Matthew Allen; Phillip J McFarland; Ismail Degani; Hojeong Yu; Erica Normandin; Divya Pathania; Jaymin M Patel; Cesar M Castro; Ralph Weissleder; Hakho Lee
Journal:  ACS Nano       Date:  2018-08-20       Impact factor: 15.881

Review 3.  Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative.

Authors:  Benjamin O Anderson; Raimund Jakesz
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

4.  Spectrum of complaints presented at a specialist breast clinic in kumasi, ghana.

Authors:  M Ohene-Yeboah; Ep Amaning
Journal:  Ghana Med J       Date:  2008-09

5.  Cost-effectiveness of breast cancer control strategies in Central America: the cases of Costa Rica and Mexico.

Authors:  Laurens M Niëns; Sten G Zelle; Cristina Gutiérrez-Delgado; Gustavo Rivera Peña; Blanca Rosa Hidalgo Balarezo; Erick Rodriguez Steller; Frans F H Rutten
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

6.  Cost-effectiveness analysis of breast cancer control interventions in Peru.

Authors:  Sten G Zelle; Tatiana Vidaurre; Julio E Abugattas; Javier E Manrique; Gustavo Sarria; José Jeronimo; Janice N Seinfeld; Jeremy A Lauer; Cecilia R Sepulveda; Diego Venegas; Rob Baltussen
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.